Sugi Predict

Sugi Predict / Compounds / SCHEMBL363882

SCHEMBL363882

SCHEMBL363882

O=Cc1ccc(C(=O)Nc2ccccc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 4/20 0.67
▸ HDAC2 Q92769 2/20 0.65
▸ HDAC8 Q9BY41 1/20 0.65
▸ HDAC6 Q9UBN7 1/20 0.65
▸ MEN1 O00255 4/20 0.59
▸ KMT2A Q03164 4/20 0.59
▸ POLB P06746 3/20 0.59
▸ KDM4E B2RXH2 2/20 0.59
▸ SIRT1 Q96EB6 2/20 0.59
▸ NPC1 O15118 1/20 0.59
▸ RAB9A P51151 1/20 0.59
▸ HTT P42858 1/20 0.58
▸ KCNK3 O14649 1/20 0.56
▸ KCNK9 Q9NPC2 1/20 0.56
▸ CACNA1B Q00975 1/20 0.56
▸ APBA1 Q02410 1/20 0.56
▸ HDAC3 O15379 1/20 0.56
▸ HDAC1 Q13547 1/20 0.56
▸ NCOR2 Q9Y618 1/20 0.56
▸ CTDSP1 Q9GZU7 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688301 0.95 PTPN1 (0.77) PTPN1HDAC2HDAC8HDAC6MEN1
SCHEMBL363343 0.93 PTPN1 (0.67) PTPN1MEN1KMT2APOLBKDM4E
Iodide SCHEMBL30758571 0.91 PTPN1 (0.65) PTPN1MEN1KMT2APOLBKDM4E
SCHEMBL16316028 0.90 NPC1 (0.59) PTPN1MEN1KMT2APOLBKDM4E
SCHEMBL15652067 0.87 ALDH1A1 (0.68) PTPN1HDAC2HDAC8HDAC6MEN1
SCHEMBL11772637 0.87 ALDH1A1 (0.68) PTPN1HDAC2HDAC8HDAC6MEN1
SCHEMBL1315526 0.86 PTPN1 (0.87) PTPN1HDAC2HDAC8HDAC6MEN1
SCHEMBL14715847 0.84 PTPN1 (0.84) PTPN1HDAC2HDAC8HDAC6MEN1
SCHEMBL15651910 0.84 HPSE (0.68) MEN1KMT2APOLBSIRT1RAB9A
SCHEMBL18434651 0.84 HDAC2 (0.57) PTPN1HDAC2HDAC8HDAC6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 — — US disclosed
CN-110357789-B N-substituted acrylamide derivative as DHODH inhibitor and preparation and application thereof 华东理工大学 2022-09-30 — — CN disclosed
CN-111116464-B (E) -4- (pyridylformylhydrazono) -N-phenylbenzamide antitumor compounds 中国医科大学 2022-09-13 — — CN disclosed
WO-2020141439-A1 HETEROCYCLIC COMPOUNDS AS MUTANT IDH INHIBITORS INTEGRAL BIOSCIENCES PRIVATE LIMITED (IN) 2020-07-09 — — WO disclosed
WO-2020141439-A1 HETEROCYCLIC COMPOUNDS AS MUTANT IDH INHIBITORS INTEGRAL BIOSCIENCES PRIVATE LIMITED (IN) 2020-07-09 — — WO disclosed
US-20200206233-A1 HETEROCYCLIC COMPOUNDS AS MUTANT IDH INHIBITORS INTEGRAL BIOSCIENCES PRIVATE LIMITED (IN) 2020-07-02 — — US disclosed
US-20200206233-A1 HETEROCYCLIC COMPOUNDS AS MUTANT IDH INHIBITORS INTEGRAL BIOSCIENCES PRIVATE LIMITED (IN) 2020-07-02 — — US disclosed
CN-111116464-A (E) -4- (pyridylformylhydrazono) -N-phenylbenzamide antitumor compounds 中国医科大学 2020-05-08 — — CN disclosed
WO-2019196714-A1 N-SUBSTITUTED ACRYLAMIDE DERIVATIVE AS DHODH INHIBITOR, AND PREPARATION AND USE THEREOF 华东理工大学 2019-10-17 — — WO disclosed
EP-2417144-B1 SYNTHESIS OF 2'-O-FUCOSYLLACTOSE GLYCOM AS (DK) 2017-08-23 — — EP disclosed
CN-101321534-A Benzodiazepines as HCV inhibitors TIBOTEC PHARM LTD (IE) 2008-12-10 — — CN disclosed
EP-1937272-A2 BENZODIAZEPINES AS HCV INHIBITORS Tibotec Pharmaceuticals Ltd. (IE) 2008-07-02 — — EP disclosed
US-20080009493-A1 Substituted Benzimidazoles and Imidazo-[4,5]-Pyridines ARIENTI KRISTEN L 2008-01-10 — — US disclosed
US-7271261-B2 Substituted benzimidazoles and imidazo-[4,5]-pyridines ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2007-09-18 — — US disclosed
EP-1435947-B1 2-PHENYL BENZIMIDAZOLES AND IMIDAZO-¬4,5|-PYRIDINES AS CDS1/CHK2-INHIBITORS AND ADJUVANTS TO CHEMOTHERAPY OR RADIATION THERAPY IN THE TREATMENT OF CANCER ORTHO MCNEIL PHARM INC (US) 2007-08-15 — — EP disclosed
WO-2007026024-A2 BENZODIAZEPINES AS HCV INHIBITORS TIBOTEC PHARMACEUTICALS LTD. (IE) 2007-03-08 — — WO disclosed
US-20030176438-A1 Substituted benzimidazoles and imidazo-[4,5]-pyridines ORTHOMCNEIL PHARMACEUTICAL, INC. 2003-09-18 — — US disclosed
US-20020094993-A1 Compositions for repelling crawling insects S.C. JOHNSON & SON, INC. 2002-07-18 — — US disclosed
EP-0784612-A1 UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-07-23 — — EP disclosed
WO-1996010559-A1 UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-04-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200206233-A1 HETEROCYCLIC COMPOUNDS AS MUTANT IDH INHIBITORS IDH1, IDH2, IDH3A PTPN1 478/4885HDAC2 617/4885HDAC8 595/4885
US-20080009493-A1 Substituted Benzimidazoles and Imidazo-[4,5]-Pyridines CDKN1A, DDB1, TMBIM6 PTPN1 1255/4885HDAC2 1002/4885HDAC8 706/4885
US-20030176438-A1 Substituted benzimidazoles and imidazo-[4,5]-pyridines CDK4, TMBIM6, CDS2 PTPN1 1891/4885HDAC2 747/4885HDAC8 1293/4885
US-20020094993-A1 Compositions for repelling crawling insects ACHE, DDT, GAP43 PTPN1 2904/4885HDAC2 1633/4885HDAC8 2741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.